Get started
Author

Taylor Kujawa

Observed name: Taylor Kujawa, PharmD
OpenAlex ID: A5115022739
Evaluation of real-world outcomes with zanubrutinib in patients with marginal zone lymphoma: Results from multicenter cohort study
2025 · Narendranath Epperla, Geoffrey Shouse, et al. · Blood · 2
Care Optimization for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm Receiving Tagraxofusp
2025 · Karolina Faysman, MSN, AOCNP, DNP-C, Joelle Rubin, NP, et al. · Journal of the Advanced Practitioner in Oncology · 2
Consolidation (Cons) and maintenance (Maint) approaches in primary central nervous system lymphoma (PCNSL) after high-dose methotrexate induction in transplant-ineligible patients
2025 · Yun Kyoung Tiger, Charlotte Zuber, et al. · Blood
PDF
Patient characteristics, treatment patterns, and outcomes in primary CNS lymphoma of T-cell origin: A multi-institution retrospective analysis
2025 · Omar Elghawy, Nishwant Swami, et al. · Blood
Real-world outcomes associated with azacitidine and venetoclax in Myelodysplastic Syndromes
2025 · Taylor Kujawa, Stacy Prelewicz, et al. · Blood
PDF
Evaluation of Pharmacist-Managed Thiopurine-Based Leukemia Maintenance Service Via a Collaborative Practice Agreement
2024 · Taylor Kujawa, Charlotte B Wagner, et al. · Blood
PDF
Works count: 6
Citation count: 4
H-index: 2
I10-index:
Year
Topic
Type